Vivos Therapeutics Inc. (VVOS) News
Filter VVOS News Items
VVOS News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
VVOS News Highlights
- VVOS's 30 day story count now stands at 6.
- Over the past 12 days, the trend for VVOS's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- OSA, DNA and MRNA are the most mentioned tickers in articles about VVOS.
Latest VVOS News From Around the Web
Below are the latest news stories about VIVOS THERAPEUTICS INC that investors may wish to consider to help them evaluate VVOS as an investment opportunity.
Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”Vivos unites influential women leaders in medicine and dentistry to drive collaboration following first ever FDA 510(k) clearance of an oral device to treat severe OSALITTLETON, Colo., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including mild to severe obstr |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayIt's time to start of the trading week with a look at the biggest pre-market stock movers worth watching on Monday morning! |
Why Is Redhill Biopharma (RDHL) Stock Down 27% Today?Redhill Biopharma stock is falling on Thursday as shares of RDHL give up some of the gains they made throughout the week. |
Why Is Vivos Therapeutics (VVOS) Stock Down 35% Today?Vivos Therapeutics stock is falling on Thursday but that's only after VVOS shares experienced a massive rally on Wednesday! |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time for a breakdown of the biggest pre-market stock movers as we check out all of the hottest news on Thursday morning! |
Vivos receives FDA 510(k) clearance for oral devices to treat severe sleep apneaThe clearance positions the company to offer an alternative to continuous positive airway pressure devices and neurostimulation implants. |
Why Is Farfetch (FTCH) Stock Down 50% Today?Farfetch stock is falling on Wednesday as shares of FTCH have been volatile alongside going private reports, delayed earnings and more. |
Why Is Vivos Therapeutics (VVOS) Stock Up 290% Today?Vivos Therapeutics stock is rocketing higher on Wednesday with heavy trading of VVOS shares following approval from the FDA! |
Vivos Therapeutics hits major milestone with FDA clearance for treating severe sleep apneaVivos Therapeutics CEO Kirk Huntsman joined Steve Darling from Proactive to announce a significant milestone for the company with its first-ever 510(k) clearance from the US Food and Drug Administr... |
UPDATE 2-US FDA clears Vivos Therapeutics' oral device for sleep apneaVivos Therapeutics said on Wednesday the U.S. health regulator has cleared its oral device for severe obstructive sleep apnea (OSA), leading a massive rally in the company's shares before the bell. Shares of the medical device maker more than doubled to $9.12 in premarket trading. The clearance is the first ever for an oral appliance, along with a mode of respiratory ventilation or exercise training program for the muscles around face, mouth and tongue, to treat moderate and severe OSA in adults. |